Researcher Profile Statistics: Ferreira, Laura
Geo Map
Region
#
NA - North America
83
AS - Asia, other
28
EU - Europe
20
OC - Oceania
3
SA - South America
1
Unknown
4
Total
139
Country
#
US - United States of America
83
SG - Singapore
21
FR - France
9
PT - Portugal
7
AU - Australia
3
CN - China
2
HK - Hong Kong
2
ID - Indonesia
2
BE - Belgium
1
BR - Brazil
1
other - Other Country
8
Total
139
City
#
Singapore
16
Hanover
10
Inglewood
6
New York
6
Coimbra
5
Ashburn
4
Boardman
3
Brisbane
2
Jakarta
2
Baton Rouge
1
other
84
Total
139
Most viewed items
#
ID: 68241 - Cyclodextrin-based dermatological formulations: Dermopharmaceutical and cosmetic applications
79
Total
79
Most type viewed
#
ID: all -
139
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: book -
0
ID: thesis -
0
ID: selected -
0
Total
139
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2024
0 12
6 28 15 38
14 26 0 0
0 0
139
Ever
139
Geo Map
Region | # |
---|---|
NA - North America | 83 |
AS - Asia, other | 28 |
EU - Europe | 20 |
OC - Oceania | 3 |
SA - South America | 1 |
Unknown | 4 |
Total | 139 |
Country | # |
---|---|
US - United States of America | 83 |
SG - Singapore | 21 |
FR - France | 9 |
PT - Portugal | 7 |
AU - Australia | 3 |
CN - China | 2 |
HK - Hong Kong | 2 |
ID - Indonesia | 2 |
BE - Belgium | 1 |
BR - Brazil | 1 |
other - Other Country | 8 |
Total | 139 |
City | # |
---|---|
Singapore | 16 |
Hanover | 10 |
Inglewood | 6 |
New York | 6 |
Coimbra | 5 |
Ashburn | 4 |
Boardman | 3 |
Brisbane | 2 |
Jakarta | 2 |
Baton Rouge | 1 |
other | 84 |
Total | 139 |
Most viewed items | # |
---|---|
ID: 68241 - Cyclodextrin-based dermatological formulations: Dermopharmaceutical and cosmetic applications | 79 |
Total | 79 |
Most type viewed | # |
---|---|
ID: all - | 139 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: book - | 0 |
ID: thesis - | 0 |
ID: selected - | 0 |
Total | 139 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 0 | 12 | 6 | 28 | 15 | 38 | 14 | 26 | 0 | 0 | 0 | 0 | 139 |
Ever | 139 |